Current management of portal hypertension
Section snippets
Natural History of portal hypertension and variceal bleeding
The management of portal hypertension should be based on an updated knowledge of its natural history. Portal hypertension is an almost unavoidable complication of cirrhosis, and it is responsible for the more lethal complications of this syndrome: gastro-esophageal varices and massive gastrointestinal bleeding, ascites, hepatorenal syndrome, and hepatic encephalopathy. Appearance of these complications represents the major cause of death and liver transplantation in patients with cirrhosis. The
Rationale for therapy
A very important concept which has been strongly substantiated in recent years is that the major factor determining the development of the complications and the clinical significance of portal hypertension is that portal pressure increases above a critical threshold value. HVPG [22], which accurately reflects portal pressure in the majority of liver diseases [23], [24], is the most commonly used method to assess portal pressure in clinical practice. Varices do not develop until the HVPG
Current recommended therapy
The treatment of portal hypertension includes the prevention of variceal hemorrhage in patients who have never bled, the treatment of the acute bleeding episode and the prevention of rebleeding in patients who have survived a bleeding episode from esophageal or gastric varices. An additional scenario may come into practice: the āpre-primaryā prophylaxis, or treatment of compensated patients without varices in order to prevent the development of varices and ascites. The main difference among
Drug therapy: beta-adrenergic blockers, nitrates and their combination
Non-selective beta-adrenergic blockers are the most widely used drugs to treat portal hypertension. However, only 30ā40% of the patients under long-term therapy reduce their portal pressure ā„20% from baseline or to levels ā¤12Ā mmHg [12]. Lack of achievement of these hemodynamic targets constitutes the strongest independent predictor of variceal bleeding or rebleeding [12], [27], indicating that the available armamentarium to treat portal hypertension is far from optimal.
The first question is the
Drugs that decrease hepatic resistance
Theoretically, in portal hypertension an ideal drug should act by decreasing intrahepatic vascular resistance, therefore decreasing portal pressure, while maintaining or enhancing hepatic blood flow. The vasodilatory effect of such a drug should be limited to the hepatic microcirculation to prevent a worsening in splanchnic/systemic vasodilatation. Furthermore, if such a drug were also capable of decreasing hepatic fibrosis and improving liver function, then many hepatologists would become
Declaration
The authors received funding from National Research Agencies (FIS, CICYT, NIHāDDK, VA) which enabled them to carry out their research.
References (184)
- et al.
Which patients with cirrhosis should undergo endoscopic screening for esophageal varices detection
Hepatology
(2001) - et al.
Natural history. Clinical-haemodynamic correlations. Prediction of the risk of bleeding
Baillieres Best Pract Res Clin Gastroenterol
(1997) - et al.
Natural history of cirrhotic patients with small esophageal varices: a prospective study
Am J Gastroenterol
(2000) - et al.
Prognostic value of hepatic venous pressure gradient measurements in alcoholic cirrhosis: a 10-year prospective study
Gastroenterology
(1996) - et al.
Natural history of portal hypertension in patients with cirrhosis
Clin Liver Dis
(2001) - et al.
Hemodynamic events in a prospective randomized trial of propranolol versus placebo in the prevention of a first variceal hemorrhage (see comments)
Gastroenterology
(1990) - et al.
Relation between portal pressure response to pharmacotherapy and risk of recurrent variceal haemorrhage in patients with cirrhosis
Lancet
(1995) - et al.
A predictive model for failure to control bleeding during acute variceal haemorrhage
J Hepatol
(1999) - et al.
Prognostic value of early measurements of portal pressure in acute variceal bleeding
Gastroenterology
(1999) - et al.
Splanchnic and systemic hemodynamics in portal hypertensive rats during hemorrhage and blood volume restitution
Gastroenterology
(1986)